Combined effect of alkyl-lysophospholipid and vincristine on proliferation, migration and invasion in human glioma cell lines in vitro

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 149-156

  Haugland, Hans K ^a   Nygaard, Svein J T ^a   Tysnes, Ole Bjørn ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Alkyllysophospholipid; Glioma; Invasion; Proliferation; Vincristine

Indexed keywords

ALKYLLYSOPHOSPHOLIPID; VINCRISTINE;

ARTICLE; BRAIN CELL; CANCER CELL CULTURE; CANCER INVASION; CELL AGGREGATION; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FLOW CYTOMETRY; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; PHOSPHATIDYLCHOLINES; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0032945844     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Westermark B, Magnusson, A and Heldin C-H: Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 8: 491-507, 1982.
2. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Petterson RF and Collins VP: Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51: 2164-2172, 1991.
3. Paulus W, Baur I, Schuppan D and Roggendorf W: Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 143: 154-163, 1993.
4. Paulus W and Tonn JC: Interactions of glioma cells and extracellular matrix. J Neurooncol 24: 87-91, 1995.
5. Haugland HK Tysnes BB and Tysnes O-B: Adhesion and migration of human glioma cells in vitro. Differential dependence on interactions between extracellular matrix and integrins. Anticancer Res 17: 1035-1043, 1997.
6. Misra-Press A, Fields AP, Samols D and Goldthwait DA: Protein kinase C isoforms in human glioblastoma cells. Glia 6: 188-197, 1992.
7. Xiao H, Goldthwait DA and Mapstone T: The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta. J Neurosurg 81: 734-740, 1994.
8. Ahmad S, Mineta T, Martuza RL and Glazer RI: Antisense expression of protein kinase C alfa inhibits the growth and tumorigenicity of human glioblastoma cells. Neurosurgery 35: 904-909, 1994.
9. Zhou, X.-J. and Rahmani, R. Preclinical and clinical pharmacology of vinca alkaloids. Drugs. 44 (Suppl. 4): 1-16, 1992.
10. Tonn J-C, Haugland HK, Saraste J, Roosen K and Laerum OD: Differential effects of vincristine and phenytoin on proliferation, migration, and invasion of human glioma cell lines. J Neurosurg 82: 1035-1043, 1995.
11. Storme GA, Berdel WE, Blitterswijk WJv, Bruyneel EA: DeBruyne GK and Mareel MM: Antiinvasive effect of 1-0-octadecyl-2-0-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro. Cancer Res 45: 351-357, 1985.
12. Berdel WE, Andreesen R and Munder PG: Synthetic alkyllysophospholipid analogs: a new class of anti-tumour agents. In: JF Kuo (ed.) Phospholipids and cellular regulation. Vol. 2, pp. 41-73, Boca Raton, FL: CRC Press, 1985.
13. Berdel WE, Greiner E, Fink U, Stavrou D, Reichert A, Rastetter J, Hoffman DR and Snyder F: Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells. Cancer Res 43: 541-545, 1983.
14. Berdel WE, Greiner E, Fink U, Zanker KS, Stavrou D, Trappe A, Fahlbusch R, Reichert A and Rastetter J: Cytotoxic effects of alkyllysophospholipids in human brain tumor cells. Oncology 41: 140-145, 1984.
15. Storme GA, Bruyneel EA, Schallier DC, Bolscher JC, Berdel WE and Marcel MM: Effect, of lipid derivatives on invasion and on surface glycoproteins of three rodent cell types. Lipids 22: 847-850, 1987.
16. Engebraaten O, Bjerkvig R and Berens ME: Effect of alkyllysophospholipid on glioma cell invasion into fetal rat brain tissue in vitro. Cancer Res 51: 1713-1719, 1991.
17. Frei E: Combination cancer therapy: presidential address. Cancer Res 32: 2593-2607, 1972.
18. Wittes RE and Goldin A: Unresolved issues in combination therapy. Cancer Treat Rep 70: 105-125, 1986.
19. Andreesen R, Modelell M, Oepke GHF, Common H, Löhr GW and Munder PG: Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids. Anticancer Res 2: 95-100, 1982.
20. Bigner D, Bigner SH, Pontén J, Westermark B, Mahaley M, Ruoslahti E, Herschman H, Eng L and Wikstrand C: Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40: 201-229, 1981.
21. Akslen LA, Andersen K-J and Bjerkvig R: Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8: 797-804, 1988.
22. Yuhas J, LiA, Martinez A and Ladman AA: simplified method for production and growth of multicellular tumor spheroids. Cancer Res 37: 3639-3643, 1977.
23. Bjerkvig R, Steinsvåg SK and Laerum OD: Reaggregation of fetal rat brain cells in a stationary culture system I: Methodology and cell identification. In Vitro Cell Dev Biol 22: 180-192, 1986.
24. Barlogie B, Goehde W, Johnston DA, Smallwood L, Schumann J, Drewiriko B and Freirich EJ: Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Res 38: 3333-3339, 1978.
25. Schulz J, Dettlaff S, Fritzsche U, Harms U, Schiebel H, Derer W, Fusenig NE, Hülsen A and Böhm M: The amido black assay: a simple and quantitative multipurpose test of adhesion, proliferation, and cytotoxicity in microplate cultures of keratinocytes (HaCaT) and other cell types growing adherently or in suspension. J Immunol Methods 167: 1-13, 1994.
26. Nederman T: Effects of vinblastine and 5-fluorouracil on glioma and thyroid cancer cell monolayers and spheroids. Cancer Res 44: 254-258, 1984.
27. Bjerkvig R, Laerum OD and Mella O: Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res 46: 4071-4079, 1986.
28. Engebraaten O, Bjerkvig R, Lund-Johansen M, Wester K, Pedersen P-H, Mørk S, Backlund E-O and Laerum OD: Interaction between human brain tumor biopsies and fetal rat brain tissue in vitro. Acta Neuropathol 81: 130-140, 1990.
29. Nygaard SJT, Pedersen P-H, Mikkelsen T, Terzis AJ, Tysnes O-B, and Bjerkvig R: Glioma cell invasion visualized by scanning confocal laser microscopy in an in vitro co-culture system. Invasion Metastasis 15: 179-188, 1995.
30. Tsuruo T. Iida H, Tsukagoshi S and Sakur Y: Enhancement of vinblastine-induced cytotoxicity by lysolecithin and phosphatidylinositol. Cancer Lett 13: 133-137, 1981.
31. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
32. Edvardsen K, Pedersen P-H, Bjerkvig R, Hermann GG, Zeuthen J, Laerum OD, Walsh FS and Bock E: Transfection of glioma cells with the neural-cell adhesion molecule NCAM: Effect on glioma-cell invasion and growth in vivo. Int J Cancer 58: 116-122, 1994.
33. Bauchinger M, Dresp KJ, Schmid E, Berdel WE and Munder PG: Cytogenetic effects of of an alkyl-lysophospholipid derivative in human peripheral lymphocytes exposed in vitro and in vivo. Mutat Res 121: 225-231, 1983.
34. Hofmann J, O'Connor P and Jackman J: The protein kinase C inhibitor ilmofosine (BM 41.440) arrests cells in G2 phase and suppresses cdc2 kinase activation through a mechanism different from that of DNA-damading agents. Biochem Biophys Res Commun 199: 937-943, 1994.
35. Kaszkin M, Fürstenberger G, Richards J, Seidler L and Kinzel V: A proposed common mechanism by which phorbol esters and epidermal growth factor delay the progression from G2 phase to mitosis in HeLa cells through phospholipid metabolites. Cancer Res 51: 4328-4335, 1991.
36. Sidoti C, Principe P, Vandamme B, Broquet C and Braquet P: Cytostatic activity of new synthetic anti-tumor aza-alkyllysophospholipids. Int J Cancer 51: 712-717, 1992.
37. Bershadsky A, Chausovky A, Becker E, Lyubimova A and Geiger B: Involvement of microtubules in the control of adhesion-dependent signal transduction. Curr Biol 6: 1279-1289, 1996.
38. Rinnerthaler G, Geiger B and Small JV: Contact formation during fibroblast locomotion: involvement of membrane ruffles and microtubules. J Cell Biol 106: 747-760, 1988.
39. Unger C, Eibl H, von Heyden H-W, Krisch B and Nagel G: Blut-Hirnschranke und penetration von Zytostatika. Klin Wochenschr 63: 565-571, 1985.
40. Mosskin M, Holst Hv, Ericson K and Norén G: The blood tumour barrier in intracranial tumours studied with X-ray computed tomography and positron emission tomography using 68-Ga-EDTA. Neuroradiology 28: 259-263, 1986.
41. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL and Wilson CB: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiation Oncol Biol Phys 18: 321-324, 1990.
42. Berens ME, Bar-Shiva E, Rosenblum ML, Piantadosi C and Modest, EJ: Effects of structural modifications of ether lipids on anti-proliferative activity against glioma cell lines. Anticancer Res 13: 401-406, 1993.
43. Danhauser-Riedl, S, Drozd A, Zafferani M, Bruntsch U, Peukert M, Sindermann H, Präuer HW, Siewert JR, Rastetter J and Berdel WP: Phase I study of weekly oral miltefosine (hexadecyl-phosphocholine) in cancer patients. Onkologie 14: 392-396, 1991.
44. Stekar J, Nössner G, Kutscher B, Engel J and Hilgard P: Synthesis, antitumor activity, and tolerability of phospholipids containing nitrogen homologues. Angew Chem Int Ed Engl 34: 238-240, 1995.